Testim 1% (testosterone gel)
Title: Testim 1% (testosterone gel)Category: MedicationsCreated: 3/15/2021 12:00:00 AMLast Editorial Review: 3/15/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 15, 2021 Category: Drugs & Pharmacology Source Type: news

Alembic Pharma's JV Aleor Dermaceuticals gets American regulator nod for Testosterone Gel
Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its ANDA for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62%, Alembic Pharmaceuticals said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news

Alembic Pharma's JV Aleor Dermaceuticals gets tentative nod from USFDA for testosterone gel
Aleor Dermaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62 per cent (20.25 mg/1.25 gm actuation), Alembic Pharmaceuticals said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 25, 2020 Category: Pharmaceuticals Source Type: news

testosterone gel (Androgel)
Title: testosterone gel (Androgel)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 7/5/2019 12:00:00 AM (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - July 5, 2019 Category: Primary Care Source Type: news

Dr Reddy's launches generic testosterone gel in US market
The company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, was approved USFDA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2019 Category: Pharmaceuticals Source Type: news

Testosterone Gel 1% (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 19, 2019 Category: Drugs & Pharmacology Source Type: news

Testosterone gel is safe for women with low sex drive 
A new study says there's no evidence that testosterone significantly increases the risk of breast cancer in women — and it does improve their sex drive. (Source: the Mail online | Health)
Source: the Mail online | Health - November 12, 2018 Category: Consumer Health News Source Type: news

AbbVie Wins Reversal of $140 Mln Verdict in Case Over AndroGel Risks AbbVie Wins Reversal of $140 Mln Verdict in Case Over AndroGel Risks
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 9, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

AbbVie wins second AndroGel liability reversal
A U.S. judge overturned a $140.1 million verdict against AbbVie in a lawsuit by a man who claimed the drugmaker misrepresented the risks of its testosterone replacement drug AndroGel. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 9, 2018 Category: Pharmaceuticals Source Type: news

AbbVie wins reversal of $140 million verdict in case over AndroGel risks
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. (Source: Reuters: Health)
Source: Reuters: Health - July 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie wins reversal of $140 million verdict in case over AndroGel risks
(Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. (Source: Reuters: Health)
Source: Reuters: Health - July 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. judge tosses $140 million verdict against AbbVie in AndroGel case
(Reuters) - A U.S. judge on Thursday overturned a $140 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. (Source: Reuters: Health)
Source: Reuters: Health - July 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge
(Reuters) - A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million. (Source: Reuters: Health)
Source: Reuters: Health - June 30, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Abbvie, Androgel partner owe $488 million in antitrust case: U.S. judge
(Reuters) - A U.S. judge on Friday found that Abbvie Inc used sham litigation to illegally prevent generic versions of testosterone gel AndroGel from getting to market and ordered the drugmaker and its partner to pay $488 million. (Source: Reuters: Health)
Source: Reuters: Health - June 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. Jury Orders AbbVie to Pay $3 Mln in AndroGel Retrial U.S. Jury Orders AbbVie to Pay $3 Mln in AndroGel Retrial
A U.S. jury ordered AbbVie to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 27, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news